Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Deep Brain Stimulation (DBS) for Obsessive Compulsive Disorder (OCD): Improving Targeting Precision

Deep Brain Stimulation (DBS) for Obsessive Compulsive Disorder (OCD) in the Bed Nucleus of the Stria Terminalis (BNST): Improving Targeting Precision

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

When comparing targeting precision between DBS in parkinsonian patients and OCD patients, an unexpected deviation from the planned targets was discovered in OCD patients (Nuttin et al., 2013). The objective of this trial is to investigate whether the use of a micro-electrode assisted technique improves targeting precision in DBS at the BNST.

Who May Be Eligible (Plain English)

Who May Qualify: - Diagnosis of OCD following the diagnostic and statistical manual of mental disorders-fourth edition (DSM-IV) criteria for OCD (300.3). - Failure of documented trials of pharmacotherapy, following an appropriate treatment algorithm for OCD. - Failure of documented trial of cognitive and behavioural therapy - Duration of illness: min. 5 year - Y-BOCS (Yale-Brown Obsessive Compulsive Scale) at least 30/40. - Age: 20-65 year Who Should NOT Join This Trial: - DSM-IV diagnosis on axis 2 of severe personality disorder in cluster A or B, especially in the case of heightened risk for acting-out behavior. - DSM-IV diagnosis on axis 3 of organic brain pathology or significant abnormalities on MRI. - Present or past history of psychotic symptoms. - Present substance abuse, or instable remission of substance abuses (i.e. no substance abuse during the last 12 months). - Any disorder affecting cognitive functioning, other than motor tics and Gilles de la Tourette's Syndrome - Mental retardation. A minimum threshold of cognitive skills is needed for adequate reporting on questionnaires and evaluation, and for technical handling of the instruments in a later faze. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Diagnosis of OCD following the diagnostic and statistical manual of mental disorders-fourth edition (DSM-IV) criteria for OCD (300.3). * Failure of documented trials of pharmacotherapy, following an appropriate treatment algorithm for OCD. * Failure of documented trial of cognitive and behavioural therapy * Duration of illness: min. 5 year * Y-BOCS (Yale-Brown Obsessive Compulsive Scale) at least 30/40. * Age: 20-65 year Exclusion Criteria: * DSM-IV diagnosis on axis 2 of severe personality disorder in cluster A or B, especially in the case of heightened risk for acting-out behavior. * DSM-IV diagnosis on axis 3 of organic brain pathology or significant abnormalities on MRI. * Present or past history of psychotic symptoms. * Present substance abuse, or instable remission of substance abuses (i.e. no substance abuse during the last 12 months). * Any disorder affecting cognitive functioning, other than motor tics and Gilles de la Tourette's Syndrome * Mental retardation. A minimum threshold of cognitive skills is needed for adequate reporting on questionnaires and evaluation, and for technical handling of the instruments in a later faze.

Treatments Being Tested

PROCEDURE

Micro-assisted technique

Medtronic DBS lead 3391-28cm Medtronic electrode array microrecording 22670

PROCEDURE

Standard technique

Medtronic DBS lead 3391-28cm

Locations (1)

UZ Leuven
Leuven, Vlaams-Brabant, Belgium